[11C]Sorafenib: Radiosynthesis and preliminary PET study of brain uptake in P-gp/Bcrp knockout mice-Reference-Cited by-同舟云学术

[11C]Sorafenib: Radiosynthesis and preliminary PET study of brain uptake in P-gp/Bcrp knockout mice

Published:2011-04 Issue:8 Volume:21 Page:2220-2223
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Asakawa Chiharu,Ogawa Masanao,Kumata Katsushi,Fujinaga Masayuki,Kato Koichi,Yamasaki Tomoteru,Yui Joji,Kawamura Kazunori,Hatori Akiko,Fukumura Toshimitsu,Zhang Ming-Rong

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference26 articles.

1. Discovery of a novel Raf kinase inhibitor.

2. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

3. Sorafenib for the Treatment of Advanced Renal Cell Carcinoma

4. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

5. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain;Fluids and Barriers of the CNS;2024-08-05

2. Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood–brain barrier;Journal of Labelled Compounds and Radiopharmaceuticals;2023-04-14

3. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma;Pharmaceuticals;2021-06-29

4. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy;Cancers;2021-03-03

5. [11C]phosgene: Synthesis and application for development of PET radiotracers;Nuclear Medicine and Biology;2021-01